SCHEMBL23449034

SCHEMBL23449034

O=C(Nc1sc(Cl)cc1C(O)O)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.42
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ MEN1 O00255 7/20 0.40
▸ RAB9A P51151 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23413471 0.77 DAO (0.47) KMT2ACASP3SENP8SENP7SENP6
SCHEMBL23450055 0.75 CRBN (0.39) REV1
SCHEMBL23413435 0.74 REV1 (0.57) RAB9AALDH1A1MAPK1GFERLMNA
SCHEMBL18154026 0.63 MEN1 (0.86) KMT2AMEN1ALDH1A1LMNAHPGD
SCHEMBL1947748 0.62 HSD17B10 (0.63) KMT2ACASP3SENP7MEN1RAB9A
SCHEMBL10344698 0.60 KMT2A (0.59) KMT2AMEN1RAB9AALDH1A1GFER
SCHEMBL2733197 0.60 RAB9A (0.45) RAB9AALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL10520043 0.60 KMT2A (0.62) KMT2AMEN1RAB9AALDH1A1LMNA
SCHEMBL12074798 0.60 KMT2A (0.62) KMT2ACASP3SENP8SENP7SENP6
SCHEMBL11465091 0.60 REV1 (0.77) KMT2ARAB9AALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021105335-A1 PIPERIDINE-2, 6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF CAPTOR THERAPEUTICS S.A. (PL) 2021-06-03 — — WO disclosed
Send feedback